Cite
HARVARD Citation
Chu, X. et al. (2022). Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC Perspective. Clinical pharmacology & therapeutics. 112 (3), pp. 501-526. [Online].